Provention Bio, Inc. Quarterly Debt-to-equity in % from Q3 2021 to Q4 2022

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Provention Bio, Inc. quarterly Debt-to-equity history and growth rate from Q3 2021 to Q4 2022.
  • Provention Bio, Inc. Debt-to-equity for the quarter ending December 31, 2022 was 49.6 %, a 180% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q4 2022 49.6 +31.9 +180% Dec 31, 2022
Q3 2022 29.9 +13.5 +81.9% Sep 30, 2022
Q2 2022 24.6 Jun 30, 2022
Q1 2022 20.6 Mar 31, 2022
Q4 2021 17.7 Dec 31, 2021
Q3 2021 16.4 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.